These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 29713125

  • 1. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
    Hernández-Aquino E, Muriel P.
    World J Gastroenterol; 2018 Apr 28; 24(16):1679-1707. PubMed ID: 29713125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R.
    Eur J Pharmacol; 2015 Jan 05; 746():96-105. PubMed ID: 25446569
    [Abstract] [Full Text] [Related]

  • 4. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells.
    Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M.
    Pharm Res; 2006 Jan 05; 23(1):82-9. PubMed ID: 16341574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.
    Algandaby MM, El-Halawany AM, Abdallah HM, Alahdal AM, Nagy AA, Ashour OM, Abdel-Naim AB.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 05; 389(4):419-28. PubMed ID: 26809353
    [Abstract] [Full Text] [Related]

  • 8. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH, Kim SC, Kim KM, Jang CH, Cho SS, Kim SJ, Ku SK, Cho IJ, Ki SH.
    Eur J Pharmacol; 2016 Jul 15; 783():92-102. PubMed ID: 27151496
    [Abstract] [Full Text] [Related]

  • 9. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ, Tao H, Huang C, Li J.
    Food Chem Toxicol; 2013 Sep 15; 59():421-7. PubMed ID: 23793039
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
    Wang R, Zhang H, Wang Y, Song F, Yuan Y.
    Int Immunopharmacol; 2017 Jun 15; 47():126-133. PubMed ID: 28391159
    [Abstract] [Full Text] [Related]

  • 11. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
    Cheong KO, Shin DS, Bak J, Lee C, Kim KW, Je NK, Chung HY, Yoon S, Moon JO.
    Arch Pharm Res; 2016 Feb 15; 39(2):279-291. PubMed ID: 26667466
    [Abstract] [Full Text] [Related]

  • 12. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
    Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA.
    Chem Biol Interact; 2018 Oct 01; 294():91-100. PubMed ID: 30138605
    [Abstract] [Full Text] [Related]

  • 13. Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
    El-Tanbouly DM, Wadie W, Sayed RH.
    Toxicol Appl Pharmacol; 2017 Aug 15; 329():224-230. PubMed ID: 28623179
    [Abstract] [Full Text] [Related]

  • 14. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
    Chen W, Zhang Z, Yao Z, Wang L, Zhang F, Shao J, Chen A, Zheng S.
    Int Immunopharmacol; 2018 Mar 15; 56():148-155. PubMed ID: 29414645
    [Abstract] [Full Text] [Related]

  • 15. Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis.
    Chen N, Geng Q, Zheng J, He S, Huo X, Sun X.
    Int J Mol Med; 2014 Oct 15; 34(4):1110-6. PubMed ID: 25069637
    [Abstract] [Full Text] [Related]

  • 16. Decoding cell death signals in liver inflammation.
    Brenner C, Galluzzi L, Kepp O, Kroemer G.
    J Hepatol; 2013 Sep 15; 59(3):583-94. PubMed ID: 23567086
    [Abstract] [Full Text] [Related]

  • 17. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective.
    Zobeiri M, Belwal T, Parvizi F, Naseri R, Farzaei MH, Nabavi SF, Sureda A, Nabavi SM.
    Curr Pharm Biotechnol; 2018 Sep 15; 19(3):196-205. PubMed ID: 29766801
    [Abstract] [Full Text] [Related]

  • 18. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
    Li X, Wang X, Han C, Wang X, Xing G, Zhou L, Li G, Niu Y.
    Free Radic Biol Med; 2013 Jul 15; 60():168-76. PubMed ID: 23459070
    [Abstract] [Full Text] [Related]

  • 19. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
    Hassan MH, Ghobara MM.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep 15; 389(9):971-83. PubMed ID: 27245167
    [Abstract] [Full Text] [Related]

  • 20. Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis.
    Bingül İ, Başaran-Küçükgergin C, Aydın AF, Çoban J, Doğan-Ekici I, Doğru-Abbasoğlu S, Uysal M.
    Environ Toxicol Pharmacol; 2016 Jul 15; 45():170-8. PubMed ID: 27314760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.